
SLU-PP-332 (5 mg Vial)
PRECLINICAL RESEARCH COMPOUND: SLU-PP-332 is a synthetic pan-agonist of estrogen-related receptors (ERRα/β/γ) studied exclusively in murine models for its ability to activate an aerobic-exercise gene program, enhance mitochondrial function, and improve endurance and cardiometabolic phenotypes. No human trials have been conducted as of November 2025. This educational protocol reflects published murine regimens using intraperitoneal administration.
- Dose
- Research dosing varies
- Frequency
- Protocol dependent
- Timing
- As per research protocol
- Duration
- Study specific
Novel metabolic compound. Research ongoing. Follow specific study protocols.
| Phase | Daily Dose (mcg) | Per-Injection Dose (mcg) | Units per Injection (mL) |
|---|---|---|---|
| Weeks 1–2 | 1250 mcg | 625 mcg | 37.5 units (0.375 mL) |
| Weeks 3–8 | 2500 mcg | 1250 mcg | 75 units (0.75 mL) |
- •Peptide Vials (SLU-PP-332, 5 mg each):
- •Insulin Syringes (U-100):
- •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- •Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
ACS Chemical Biology (2023)
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity
View sourceJournal of Pharmacology and Experimental Therapeutics (2024)
A Synthetic ERR Agonist Alleviates Metabolic Syndrome
View sourceCirculation (2024)
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function
View sourceAmerican Journal of Pathology (2023)
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney
View sourceCDC (2024)
Vaccine Administration: Subcutaneous Injection (Job Aid)
View sourceCDC (2024)
Vaccine Administration—Best Practices (Subcutaneous Injections)
View sourceAdvanced Drug Delivery Reviews (2023)
Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems
View sourceJournal of Chromatography B (2023)
Tutorial review for peptide assays: An ounce of prevention is worth a pound of cure?
View sourceClinical Chemistry (2016)
Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays
View sourceJournal of Pharmaceutical Sciences (2012)
Use of glass transitions in carbohydrate excipient design for lyophilized biopharmaceuticals
View sourceActa Pharmacologica Sinica (2015)
The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases
View source
Educational content adapted from peptidedosages.com. Not medical advice.